The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Genetic and pharmacological analysis of prostanoid receptor function
Open accessAbstract
Prostaglandins and their precursors Membrane prostanoid receptors: studies in knockout miceEight types and subtypes of membrane prostanoid receptors are conserved in mammals from mouse to human (2): the PGD receptor (DP), four subtypes of the PGE receptor (EP1, EP2, EP3, and EP4), the PGF receptor (FP), the PGI receptor (IP), and the TxA receptor (TP).All are G protein-coupled rhodopsin-type receptors with seven transmembrane domains, and each is encoded by different genes.In addition, there are several splice variants of the EP3, FP, and TP receptors, which differ only in their C-terminal tails.Among the eight types and subtypes, the IP, DP, EP2, and EP4 receptors mediate a cAMP rise and have been termed "relaxant" receptors, whereas the TP, FP, and EP1 receptors induce calcium mobilization and constitute a "contractile" receptor group.The remaining receptor, EP3, induces a decline in cAMP levels and has been termed the "inhibitory" receptor.However, the effects of prostanoids on these G protein-coupled signaling pathways may change as a function of ligand concentration or structure.Thus, while PGI 2 analogs ligate the IP and activate adenylate cyclase via G s in a dosedependent manner, higher concentrations of the ligand couple the IP to phospholipase C activation and calcium mobilization (3), probably via G q .Similarly, activation of the FP in cardiomyocytes by either PGF 2α , its cognate ligand, or 8,12-iso-iPF 2α -III, a PGF 2α isomeric
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90193-0 · Cited by 2,858
Prostanoid Receptors: Structures, Properties, and Functions
Narumiya, S., Sugimoto, Y., & Ushikubi, F. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.4.1193 · Cited by 2,412
Self-citationMcAdam, B. F., Catella-Lawson, F., Mardini, I. A., Kapoor, S., Lawson, J. A., & FitzGerald, G. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.272 · Cited by 1,305
Self-citationInducible cyclooxygenase may have anti-inflammatory properties
Gilroy, D. W., Colville-Nash, P. R., Willis, D., Chivers, J., Paul-Clark, M. J., & Willoughby, D. A. (1999) · Nature Medicine · doi:10.1038/9550 · Cited by 1,242
Lehmann, J. M., Lenhard, J. M., Oliver, B. B., Ringold, G. M., & Kliewer, S. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3406 · Cited by 1,110
Hirai, H., Tanaka, K., Yoshie, O., Ogawa, K., Kenmotsu, K., Takamori, Y., Ichimasa, M., Sugamura, K., Nakamura, M., Takano, S., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.2.255 · Cited by 1,099
Altered pain perception and inflammatory response in mice lacking prostacyclin receptor
Murata, T., Ushikubi, F., Matsuoka, T., Hirata, M., Yamasaki, A., Sugimoto, Y., Ichikawa, A., Aze, Y., Tanaka, T., Yoshida, N., et al. (1997) · Nature · doi:10.1038/41780 · Cited by 773
Self-citationProstaglandin D 2 as a Mediator of Allergic Asthma
Matsuoka, T., Hirata, M., Tanaka, H., Takahashi, Y., Murata, T., Kabashima, K., Sugimoto, Y., Kobayashi, T., Ushikubi, F., Aze, Y., et al. (2000) · Science · doi:10.1126/science.287.5460.2013 · Cited by 743
Self-citationMixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes
Tilley, S. L., Coffman, T. M., & Koller, B. H. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200113416 · Cited by 726
Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes
Tilley, S. L., Coffman, T. M., & Koller, B. H. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13416 · Cited by 725
Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3
Ushikubi, F., Segi, E., Sugimoto, Y., Murata, T., Matsuoka, T., Kobayashi, T., Hizaki, H., Tuboi, K., Katsuyama, M., Ichikawa, A., et al. (1998) · Nature · doi:10.1038/26233 · Cited by 677
Self-citationPeters, J. M., Lee, S. S. T., Li, W., Ward, J. M., Gavrilova, O., Everett, C., Reitman, M. L., Hudson, L. D., & Gonzalez, F. J. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.14.5119-5128.2000 · Cited by 633
Why there are two cyclooxygenase isozymes
Smith, W. L., & Langenbach, R. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13271 · Cited by 611
Failure of Parturition in Mice Lacking the Prostaglandin F Receptor
Sugimoto, Y., Yamasaki, A., Segi, E., Tsuboi, K., Aze, Y., Nishimura, T., Oida, H., Yoshida, N., Tanaka, T., Katsuyama, M., et al. (1997) · Science · doi:10.1126/science.277.5326.681 · Cited by 608
Self-citationCyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdelta
Lim, H., Gupta, R. A., Ma, W.-G., Paria, B. C., Moller, D. E., Morrow, J. D., DuBois, R. N., Trzaskos, J. M., & Dey, S. K. (1999) · Genes & Development · doi:10.1101/gad.13.12.1561 · Cited by 587
Kiriyama, M., Ushikubi, F., Kobayashi, T., Hirata, M., Sugimoto, Y., & Narumiya, S. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701367 · Cited by 510
Self-citationHizaki, H., Segi, E., Sugimoto, Y., Hirose, M., Saji, T., Ushikubi, F., Matsuoka, T., Noda, Y., Tanaka, T., Yoshida, N., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.10501 · Cited by 465
Self-citationSalt–sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor
Kennedy, C. R. J., Zhang, Y., Brandon, S., Guan, Y., Coffee, K., Funk, C. D., Magnuson, M. A., Oates, J. A., Breyer, M. D., & Breyer, R. M. (1999) · Nature Medicine · doi:10.1038/5583 · Cited by 391
Shinmura, K., Tang, X.-L., Wang, Y., Xuan, Y.-T., Liu, S.-Q., Takano, H., Bhatnagar, A., & Bolli, R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.18.10197 · Cited by 381
Adderley, S. R., & Fitzgerald, D. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.8.5038 · Cited by 371
Patrono, C., Patrignani, P., & Rodríguez, L. A. G. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13418 · Cited by 364
The prostaglandin receptor EP4 triggers remodelling of the cardiovascular system at birth
Nguyen, M., Camenisch, T., Snouwaert, J. N., Hicks, E., Coffman, T. M., Anderson, P. A. W., Malouf, N. N., & Koller, B. H. (1997) · Nature · doi:10.1038/36342 · Cited by 363
Role of the prostaglandin E receptor subtype EP1 in colon carcinogenesis.
Watanabe, K., Kawamori, T., Nakatsugi, S., Ohta, T., Ohuchida, S., Yamamoto, H., Maruyama, T., Kondo, K., Ushikubi, F., Narumiya, S., et al. (1999) · PubMed · Cited by 351
Self-citationPatent Ductus Arteriosus and Neonatal Death in Prostaglandin Receptor EP4-Deficient Mice
Segi, E., Sugimoto, Y., Yamasaki, A., Aze, Y., Oida, H., Nishimura, T., Murata, T., Matsuoka, T., Ushikubi, F., Hirose, M., et al. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8461 · Cited by 313
Self-citationCoagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2.
Thomas, D. W., Mannon, R. B., Mannon, P. J., Latour, A., Oliver, J. A., Hoffman, M., Smithies, O., Koller, B. H., & Coffman, T. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci5116 · Cited by 276
McAdam, B. F., Mardini, I. A., Habib, A., Burke, A., Lawson, J. A., Kapoor, S., & FitzGerald, G. A. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9523 · Cited by 253
Self-citationReproductive failure and reduced blood pressure in mice lacking the EP2 prostaglandin E2 receptor
Tilley, S. L., Audoly, L. P., Hicks, E. H., Kim, H.-S., Flannery, P. J., Coffman, T. M., & Koller, B. H. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6579 · Cited by 249
Cayatte, A. J., Du, Y., Oliver-Krasinski, J., Lavielle, G., Verbeuren, T. J., & Cohen, R. A. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.7.1724 · Cited by 237
Regulated formation of eicosanoids
Fitzpatrick, F. A., & Soberman, R. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13241 · Cited by 233
Impaired Bone Resorption to Prostaglandin E2 in Prostaglandin E Receptor EP4-knockout Mice
Miyaura, C., Inada, M., Suzawa, T., Sugimoto, Y., Ushikubi, F., Ichikawa, A., Narumiya, S., & Suda, T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002079200 · Cited by 208
Self-citationShinomiya, S., Naraba, H., Ueno, A., Utsunomiya, I., Maruyama, T., Ohuchida, S., Ushikubi, F., Yuki, K., Narumiya, S., Sugimoto, Y., et al. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00586-x · Cited by 172
Self-citationKnockout of the Murine Prostaglandin EP2 Receptor Impairs Osteoclastogenesis in Vitro
Li, X. (2000) · Endocrinology · doi:10.1210/en.141.6.2054 · Cited by 164
Narumiya, S., Ohno, K., Fukushima, M., & Fujiwara, M. (1987) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39070-1 · Cited by 138
Self-citationPhosphorylation of the Thromboxane Receptor α, the Predominant Isoform Expressed in Human Platelets
Habib, A., FitzGerald, G. A., & Maclouf, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.5.2645 · Cited by 136
Self-citationDistinct roles of prostaglandin H synthases 1 and 2 in T-cell development
Rocca, B., Spain, L. M., Puré, E., Langenbach, R. J., Patrono, C., & FitzGerald, G. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6400 · Cited by 133
Self-citationMiggin, S. M., & Kinsella, B. T. (1998) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(98)00109-3 · Cited by 131
Sakuma, Y., Tanaka, K., Suda, M., Yasoda, A., Natsui, K., Tanaka, I., Ushikubi, F., Narumiya, S., Segi‐Nishida, E., Sugimoto, Y., et al. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.2.218 · Cited by 121
Self-citationKunapuli, P., Lawson, J. A., Rokach, J., Meinkoth, J. L., & FitzGerald, G. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.35.22442 · Cited by 119
Self-citationTakeuchi, K., Ukawa, H., Kato, S., Furukawa, O., Araki, H., Sugimoto, Y., ICHIKAWA, A., Ushikubi, F., & Narumiya, S. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70398-7 · Cited by 117
Self-citationIdentification of specific EP receptors responsible for the hemodynamic effects of PGE2
Audoly, L., Tilley, S. L., Goulet, J. L., et al. (1999) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1999.277.3.h924 · Cited by 99
Is cyclooxygenase-2 the alpha and the omega in cancer?
Prescott, S. M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10241 · Cited by 94
Ueno, A., Naraba, H., Ikeda‐Matsuo, Y., Ushikubi, F., Murata, T., Narumiya, S., & Oh‐ishi, S. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)00420-3 · Cited by 94
Self-citationUrinary concentrating function in mice lacking EP3receptors for prostaglandin E2
Fleming, E. F., Athirakul, K., Oliverio, M. I., Key, M. L., Goulet, J. L., Koller, B. H., & Coffman, T. M. (1998) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1998.275.6.f955 · Cited by 92
EP2 receptor mediates bronchodilation by PGE2 in mice
Sheller, J. R., Mitchell, D. B., Meyrick, B. O., et al. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.88.6.2214 · Cited by 91
Internalization and Sequestration of the Human Prostacyclin Receptor
Smyth, E. M., Austin, S. C., Reilly, M. P., & FitzGerald, G. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003873200 · Cited by 90
Self-citationCharacterization of Murine Vasopressor and Vasodepressor Prostaglandin E2Receptors
Zhang, Y., Guan, Y., Schneider, A., Brandon, S., BREYER, R. M., & Breyer, M. D. (2000) · Hypertension · doi:10.1161/01.hyp.35.5.1129 · Cited by 87
Rocca, B., Loeb, A. L., Strauss, J. F., Vezza, R., Habib, A., Li, H., & FitzGerald, G. A. (2000) · Nature Medicine · doi:10.1038/72334 · Cited by 57
Self-citationOkada, Y., Hara, A., Ma, H., Xiao, C., Takahata, O., Kohgo, Y., Narumiya, S., & Ushikubi, F. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703627 · Cited by 49
Self-citation
Research works printed but not linked: 7
- Watanabe, 1999, Cancer Res, 59, 5093
- 10.1172/JCI200113418 · doi:10.1172/jci200113418 · Paper page
- Thevenon, 2001, Clin Chem, 47, 768, 10.1093/clinchem/47.4.768 · doi:10.1093/clinchem/47.4.768
- Narumiya, 1987, J Pharmacol Exp Ther, 242, 306
- 10.1007/s004390000267 · doi:10.1007/s004390000267
- Audoly, 1999, Am J Physiol, 277, H924
- Fleming, 1998, Am J Physiol, 275, F955
Cited by
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
Funk, C. D. (2001) · Science · doi:10.1126/science.294.5548.1871 · Cited by 3,817
Prostaglandins and Inflammation
Ricciotti, E., & FitzGerald, G. A. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.207449 · Cited by 3,803
Self-citationMetabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets
Wang, B., Wu, L., Chen, J., Dong, L., Chen, C., Wen, Z., Hu, J., Fleming, I., & Wang, D. W. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00443-w · Cited by 1,414
Grosser, T. (2005) · Journal of Clinical Investigation · doi:10.1172/jci27291 · Cited by 1,027
Health Implications of High Dietary Omega-6 Polyunsaturated Fatty Acids
Patterson, E., Wall, R., Fitzgerald, G. F., Ross, R. P., & Stanton, C. (2012) · Journal of Nutrition and Metabolism · doi:10.1155/2012/539426 · Cited by 883
Self-citation
Metadata
- Authors
- Narumiya, S., & FitzGerald, G. A.
- Venue
- Journal of Clinical Investigation
- Published
- 2001-07-01
- Volume
- 108
- Issue
- 1
- Pages
- 25-30
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2074126807
- Cited by
- 568
- References
- 48
- FWCI
- 20.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.